Introduction. The emergence of multidrug-resistant Salmonella Typhimurium strains has increased the need for safe, alternative therapies from natural sources with antibacterial properties.
Hypothesis/Gap Statement. There are no published data regarding the use of chitosan propolis nanocomposite (CPNP) either alone or in combination with antibiotics as antimicrobials against S. Typhimurium, especially in Egypt.
Aim. This study evaluated the antibacterial activities of five antimicrobials [apramycin, propolis, chitosan nanoparticles (CNPs), chitosan propolis nanocomposite (CPNP) and CPNP +apramycin] against ten virulent and multidrug-resistant (MDR) S. Typhimurium field strains recovered from diarrheic rabbits through in vitro and in vivo study.
Methodology. The expression levels of three virulence genes of S. Typhimurium strains were determined by quantitative reverse-transcription PCR (RT-qPCR) after exposure to sub-inhibitory concentrations of apramycin, propolis, CNPs, CPNP alone, and CPNP +apramycin. Additionally, 90 New Zealand rabbits were divided into control and experimentally S. Typhimurium-infected groups. The infected rabbits were orally administered saline solution (infected–untreated); 10 mg apramycin/kg (infected–apramycin-treated); 50 mg propolis/kg (infected–propolis-treated); 15 mg CPNP/kg (infected–CPNP-treated) and 15 mg CPNP +10 mg apramycin/kg (infected–CPNP +apramycin-treated) for 5 days.
Results. The RT-qPCR analysis revealed different degrees of downregulation of all screened genes. Furthermore, the treatment of infected rabbits with CPNP or CPNP +apramycin significantly improved performance parameters, and total bacterial and
Salmonella
species counts, while also modulating both oxidative stress and altered liver and kidney parameters.
Conclusion. This work demonstrates the use of CPNP alone or in combination with apramycin in the treatment of S. Typhimurium in rabbits.
A total of 90 one-day-old male broiler chicks were fed on balanced ration for 15 days and then divided into 3 equal groups. Control group fed ration probiotic free, group 2 and 3 fed ration supplemented with probiotic at concentration levels 0.5 and 1.0g/kg ration respectively for 4 weeks.It was found that probiotic improve body weight gain and feed conversion ratio. Relative organs weights were not altered in groups of birds fed ration mixed with probiotic. Serum values of biochemical parameter (AST, ALT, ALP, total protein, A/G ratio, Ph) were not significantly changed in comparison to control group. Probiotic enhance the immune response of broiler chickens in a dose dependent relation as documented by increasing the serumNDHI antibody geometric mean titres to ND vaccine, phagocyte percentage and phagocytic index of peripheral blood monocyte of broiler chickens. We concluded that probiotic composed of 3 strains of bacteria (Pediococcus acidilactici, Pediococaoccus pentosaceus and Bacillus Amylolique-faciens) in addition to 2 strains of yeast( Pichia farinose and Dekera anomala ) enhance body weight gain, feed conversion, growth performance and Newcastle disease antibody titres in broiler chickens. Moreover, probiotic was safe as proved by serum biochemical profile and relative organ weight of male broiler chickens.
The present study was carried out to evaluate the antimicrobial activity of ethanol plant extract of rosemary (Rosmarinus officinalis) and / with five antimicrobial agents of different mechanisms (oxytetracycline Hcl, amoxicillin, cefquinome, sulphaquinoxaline and danofloxacin) against field strain of S. aureus. By using agar well diffusion method, the mean zone of inhibition (mm) of ethanol extract
Concurrent administration of drugs may alter their pharmacokinetic parameters, so; investigation to what extent bromhexine hydrochloride affects the pharmacokinetic behavior of tilmicosin was our aim of this work. Ten broiler chickens were classified into two groups as follow, the first one (tilmicosin group) was given single oral dose of tilmicosin (20 mg/kg.b.wt.) while the 2nd (pre-treated group) was given single oral dose of bromhexine hydrochloride (1 mg/kg.b.wt.) followed by single oral dose of tilmicosin (20 mg/kg.b.wt.) one hour later. The serum concentration of tilmicosin was measured using High Pressure Liquid Chromatography (HPLC) method. The results revealed that the mean serum concentrations of tilmicosin were significantly lower in pre-treated group when compared with tilmicosin alone group at the corresponding time intervals. Pharmacokinetic parameters were significantly differed (p<0.001) between both groups. The maximum serum concentration were (Cmax0.70±0.02, 0.81±0.04µg/ml), achieved at Tmax of (tmax 0.89±0.16, and 2.10±0.06h), absorption half-life (t0.5ab) of 0.16±0.08, and 0.37±0.01 hour, area under curve (AUC) of 12.96±0.42 and 16.73±0.42µg.h/ml) in tilmicosin-bromhexine and tilmicosin alone groups respectively. In conclusion, based on the obtained pharmacokinetic parameters, these findings showed that bromhexine accelerates the tilmicosin penetration into body tissues, achieving higher and faster concentrations than when given tilmicosin alone.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.